Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma

被引:6
作者
Chen, Jianan [1 ]
Zhang, Weibin [4 ]
Bao, Jingwen [5 ]
Wang, Kun [6 ]
Zhao, Qiannan [3 ]
Zhu, Yuli [3 ]
Chen, Yanling [2 ,3 ]
机构
[1] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Ultrasound, Shanghai, Peoples R China
[5] Hexi Univ, Sch Med Sci, Zhangye, Peoples R China
[6] Binzhou Med Univ, Affiliated Hosp, Dept Ultrasound, Binzhou, Peoples R China
关键词
Ultrasound; Deep learning; Combined hepatocellular-cholangiocarcinoma; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; DIAGNOSIS; CLASSIFICATION; RESECTION;
D O I
10.1007/s00261-023-04089-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesThe current study developed an ultrasound-based deep learning model to make preoperative differentiation among hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular-cholangiocarcinoma (cHCC-ICC).MethodsThe B-mode ultrasound images of 465 patients with primary liver cancer were enrolled in model construction, comprising 264 HCCs, 105 ICCs, and 96 cHCC-ICCs, of which 50 cases were randomly selected to form an independent test cohort, and the rest of study population was assigned to a training and validation cohorts at the ratio of 4:1. Four deep learning models (Resnet18, MobileNet, DenseNet121, and Inception V3) were constructed, and the fivefold cross-validation was adopted to train and validate the performance of these models. The following indexes were calculated to determine the differential diagnosis performance of the models, including sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), F-1 score, and area under the receiver operating characteristic curve (AUC) based on images in the independent test cohort.ResultsBased on the fivefold cross-validation, the Resnet18 outperformed other models in terms of accuracy and robustness, with the overall training and validation accuracy as 99.73% (+/- 0.07%) and 99.35% (+/- 0.53%), respectively. Furthers validation based on the independent test cohort suggested that Resnet 18 yielded the best diagnostic performance in identifying HCC, ICC, and cHCC-ICC, with the sensitivity, specificity, accuracy, PPV, NPV, F1-score, and AUC of 84.59%, 92.65%, 86.00%, 85.82%, 92.99%, 92.37%, 85.07%, and 0.9237 (95% CI 0.8633, 0.9840).ConclusionUltrasound-based deep learning algorithm appeared a promising diagnostic method for identifying cHCC-ICC, HCC, and ICC, which might play a role in clinical decision making and evaluation of prognosis.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 39 条
[1]   A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence-Powered Ultrasound for Improving Clinical Workflow [J].
Akkus, Zeynettin ;
Cai, Jason ;
Boonrod, Arunnit ;
Zeinoddini, Atefeh ;
Weston, Alexander D. ;
Philbrick, Kenneth A. ;
Erickson, Bradley J. .
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2019, 16 (09) :1318-1328
[2]  
ALLEN RA, 1949, AM J PATHOL, V25, P647
[3]   Combined hepatocellular-cholangiocarcinoma: An update [J].
Beaufrere, Aurelie ;
Calderaro, Julien ;
Paradis, Valerie .
JOURNAL OF HEPATOLOGY, 2021, 74 (05) :1212-1224
[4]   Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response [J].
Borhani, Amir A. ;
Catania, Roberta ;
Velichko, Yuri S. ;
Hectors, Stefanie ;
Taouli, Bachir ;
Lewis, Sara .
ABDOMINAL RADIOLOGY, 2021, 46 (08) :3674-3685
[5]   Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma [J].
Bridgewater, John ;
Galle, Peter R. ;
Khan, Shahid A. ;
Llovet, Josep M. ;
Park, Joong-Won ;
Patel, Tushar ;
Pawlik, Timothy M. ;
Gores, Gregory J. .
JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1268-1289
[6]   State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma [J].
Castaldo, Anna ;
De Lucia, Davide Raffaele ;
Pontillo, Giuseppe ;
Gatti, Marco ;
Cocozza, Sirio ;
Ugga, Lorenzo ;
Cuocolo, Renato .
DIAGNOSTICS, 2021, 11 (07)
[7]   Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Experience of a Single Center [J].
Chang, Cheng-Chih ;
Chen, Ying-Ju ;
Huang, Tzu-Hao ;
Chen, Chun-Han ;
Kuo, Fang-Ying ;
Eng, Hock-Liew ;
Yong, Chee-Chien ;
Liu, Yueh-Wei ;
Lin, Ting-Lung ;
Li, Wei-Feng ;
Lin, Yu-Hung ;
Lin, Chih-Che ;
Wang, Chih-Chi ;
Chen, Chao-Long .
ANNALS OF TRANSPLANTATION, 2017, 22 :115-120
[8]   Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature [J].
Dong, Yi ;
Teufel, Andreas ;
Trojan, Joerg ;
Berzigotti, Annalisa ;
Cui, Xin Wu ;
Dietrich, Christoph F. .
DIGESTIVE AND LIVER DISEASE, 2018, 50 (04) :401-407
[9]   Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives [J].
Feng, Bing ;
Ma, Xiao-Hong ;
Wang, Shuang ;
Cai, Wei ;
Liu, Xia-Bi ;
Zhao, Xin-Ming .
WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (32) :5341-5350
[10]   Systematic review: Radiomics for the diagnosis and prognosis of hepatocellular carcinoma [J].
Harding-Theobald, Emily ;
Louissaint, Jeremy ;
Maraj, Bharat ;
Cuaresma, Edward ;
Townsend, Whitney ;
Mendiratta-Lala, Mishal ;
Singal, Amit G. ;
Su, Grace L. ;
Lok, Anna S. ;
Parikh, Neehar D. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (07) :890-901